| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/16/2005 | WO2005012566A3 Use of polymorphisis in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy |
| 06/16/2005 | WO2005007144A3 Method of diagnosis and treatment for asthma based on haplotype association |
| 06/16/2005 | WO2005005598A3 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 06/16/2005 | WO2005003154A8 Compositions and methods for the diagnosis and treatment of tumor |
| 06/16/2005 | WO2004109255A3 Rapid screening of biogenic particles in collected aerosols |
| 06/16/2005 | WO2004108840A8 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 06/16/2005 | WO2004106367A3 Enterococcus antigens |
| 06/16/2005 | WO2004103939A3 Assay method and apparatus |
| 06/16/2005 | WO2004101812A3 Chromogenic plating medium for the rapid presumptive identification of bacillus anthracis, bacillus cereus, and bacillus thuringiensis |
| 06/16/2005 | WO2004099782A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 06/16/2005 | WO2004097032A3 Method for nucleic acid sequencing |
| 06/16/2005 | WO2004092413A3 High throughput functional genomic screening methods for osteoarthritis |
| 06/16/2005 | WO2004091548A3 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| 06/16/2005 | WO2004087877A3 Selected rna motifs to include cell death and/or apoptosis |
| 06/16/2005 | WO2004087281A3 Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system |
| 06/16/2005 | WO2004084804A3 Detection and monitoring of lung cancer |
| 06/16/2005 | WO2004083803A3 Test methods for determining the intracellular concentration of cyclic nucleotides |
| 06/16/2005 | WO2004074505A3 Method for determining functional sites in a protein |
| 06/16/2005 | WO2004058166A3 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 06/16/2005 | WO2004043238A8 Biomarkers for intra-amniotic inflammation |
| 06/16/2005 | WO2004031360A3 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 06/16/2005 | WO2003091390A3 Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher |
| 06/16/2005 | WO2003082072A3 Methods for selecting treatment regimens and predicting outcomes in cancer patients |
| 06/16/2005 | WO2003033646A3 Compositions and methods for the modulation of viral maturation |
| 06/16/2005 | US20050132448 Using streptomyces infected tubers as tools in diagnosing diabetes; macrolide antibiotic and onset of pancreatic disorders |
| 06/16/2005 | US20050132437 Encoding dihydrodipicolinic acid synthase that are useful for generating transgenic events |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050132427 Monitoring cell proliferation in rodent animal model after inoculation with tumor cell line; cancer propagation and antiproliferative agents |
| 06/16/2005 | US20050131314 Methods and apparatus for the rapid detection of microorganisms collected from infected sites |
| 06/16/2005 | US20050131221 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 06/16/2005 | US20050131219 Methods for reducing complexity of a sample using small epitope antibodies |
| 06/16/2005 | US20050131215 Nucleotide sequences coding ribosomal polypeptides for use as tool in detection of modulator for treatment of bacterial infection; bactericides; microbiocides |
| 06/16/2005 | US20050131212 Neurogenic peptide for use in enhancement of neuronal migration, proliferation, survival, differentiation, and/or neurite outgrowth |
| 06/16/2005 | US20050131057 Taxane chemosensitivity prediction test |
| 06/16/2005 | US20050131006 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
| 06/16/2005 | US20050130928 Modulating mammalian midkine activity; alters pulmonary vasculature development and smooth muscle cell development |
| 06/16/2005 | US20050130927 For treating neoplasm, hypoproliferation, hyperproliferation, degenerative and neurodegenerative diseases, ischaemia, immune system disorder, infectious disease, or metabolic dysfunction |
| 06/16/2005 | US20050130926 Drug screening; cancer diagnosis; host cells |
| 06/16/2005 | US20050130923 4'-thionucleosides and oligomeric compounds |
| 06/16/2005 | US20050130876 Use of substances for treating tumors |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130296 Apparatus comprising coated electrodes for use in detecting preferential biopolymers in solution; biosensors |
| 06/16/2005 | US20050130294 Immunoassay; substrate; fluid flow circuits; separation membrane; absorbers; release pads |
| 06/16/2005 | US20050130292 Smart disposable plastic lab-on-a-chip for point-of-care testing |
| 06/16/2005 | US20050130287 Purifying process of soluble proteins of the l.obliqua bristles through prothrombin activation: process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction II, n-terminal and internal fragments sequences |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130285 Reference solution |
| 06/16/2005 | US20050130256 Propagating previously uncultivatible microorganisms in bioreactor; nutrient broth comprising companion bacteria for culturing fungi, protozoa, viruses and microalgae |
| 06/16/2005 | US20050130255 Process control based on microbiological activity |
| 06/16/2005 | US20050130254 Apparatus comprising bioscaffold meshwork embedded with cultured liver cell for use toxicity screening tool |
| 06/16/2005 | US20050130253 Disposable wipe of nonwoven web of cellulosic fibers coated with Reichardt's dye; detectable color change upon exposure to bacteria |
| 06/16/2005 | US20050130252 Stabilized susceptibility tests of aerobic pathogens |
| 06/16/2005 | US20050130250 Using melatonin-signaling impairment as diagnostic indicator bone disorders |
| 06/16/2005 | US20050130248 Biosensor carrying redox enzymes |
| 06/16/2005 | US20050130242 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 06/16/2005 | US20050130240 Mannose enclosed metallic nanoparticles for use as diagnostic and drug delivery tools |
| 06/16/2005 | US20050130237 Using transgenic cell as tool in determining toxicity of therapeutic agents; drug screening |
| 06/16/2005 | US20050130235 Method and compositions for the detection of protein glycosylation |
| 06/16/2005 | US20050130231 Using blood mononuclear cells as tool in monitoring immunological response to plant extracts; drug screening; side effect reduction; ginseng and cancer treatment |
| 06/16/2005 | US20050130229 Representing data from experiments on related combinatorial libraries; rational drug design and data management |
| 06/16/2005 | US20050130220 High speed drug screening; (near) infrared spectrometry, nuclear magnetic resonance, X-ray diffractometry, neutron diffractometry, light/electron microscopy, harmonic generation, circular/linear dichroism spectrometry, differential scanning calorimetry |
| 06/16/2005 | US20050130219 Using host transduced cells as bioreactor for expression and isolation of preferential gene products |
| 06/16/2005 | US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130217 Using signal intensity of hybridized oligonucleotides to identify chromosomal amplification and deletions in genome; predicting genomic complexity |
| 06/16/2005 | US20050130216 For use in detecting the presence of a target nucleic acid sequence in a sample |
| 06/16/2005 | US20050130215 Using weighted color ratio to accurately determine gene expression patterns; bioinformatics |
| 06/16/2005 | US20050130213 Selective ligation and amplification assay |
| 06/16/2005 | US20050130212 Digital representation of interacting biochemical pathways; bioinformatics; cancer diagnostics |
| 06/16/2005 | US20050130211 Determining quantity of analyte initially present in chemical and/or biological reaction via cyclic replication; bioinformatics |
| 06/16/2005 | US20050130208 Displacement assay for detection of small molecules |
| 06/16/2005 | US20050130207 Cluster complex or colloid comprised of metal core particle and probes for visualizing the localization or distribution of substances within cells, tissue sections, organelles or organs |
| 06/16/2005 | US20050130206 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 06/16/2005 | US20050130202 Using presence of microsatellite sequences in mitochondrial polymerase g (POLG) gene as tool in detection and treatment of reproductive disorders |
| 06/16/2005 | US20050130201 Splint-assisted enzymatic synthesis of polyribounucleotides |
| 06/16/2005 | US20050130200 Labeled polynucleotide is subjected to hybridization with oligonucleotide probes fixed respectively to regions on a supporting material, with a first restriction enzyme, a single-stranded moiety of the labeled polynucleotide having failed to form a double strand with each probe is separated |
| 06/16/2005 | US20050130199 Mutations in WNT-frizzled signaling pathways associated with osteoarthritis |
| 06/16/2005 | US20050130198 Processing and amplifying target nucleic acid sequence present in a fluid sample via processive reaction in open-mouthed vessel containing solid support; genomic analysis and gene diagnostics |
| 06/16/2005 | US20050130197 Homogeneous fluorescence polarization assay for high throughput screening |
| 06/16/2005 | US20050130195 Functional molecule and process for producing the same |
| 06/16/2005 | US20050130194 Generating cDNA libraries via reverse transcription; differential expression analysis of mRNA; genomic analysis |
| 06/16/2005 | US20050130193 Methods for detecting, diagnosing and treating human renal cell carcinoma |
| 06/16/2005 | US20050130192 Apparatus and method for identifying therapeutic targets using a computer model |
| 06/16/2005 | US20050130191 forming multibranched polyamide amine dendrimer molecules on walls of a U-shaped flow channel through which a solution containing target DNA is flowed;binding probe DNA to tips of said multibranched polyamide amine dendrimer molecules; andextracting said target DNA by hybridization with probes |
| 06/16/2005 | US20050130190 Mutations in ion channel proteins associated with sudden cardiac death |
| 06/16/2005 | US20050130189 Using chromic visceral hypersensitivity (CVH) polypeptide concentration as diagnostic tool in detection of inflammatory disorders |
| 06/16/2005 | US20050130188 Methods for detecting target analytes and enzymatic reactions |
| 06/16/2005 | US20050130187 Using transcriptional patterning to classify preferential gene groupings; computer modeling and genetic analysis |
| 06/16/2005 | US20050130186 Meningitis detection chip and fabrication method thereof and method of detecting meningitis and primer set for meningitis detection |
| 06/16/2005 | US20050130185 Sepsis detection chip and fabrication method thereof and method of detecting sepsis |
| 06/16/2005 | US20050130184 Expression vector comprising coded looped RNA sequences for use in the prevention and treatment nervous system disorders; RNA interference |
| 06/16/2005 | US20050130183 Real-time PCR monitoring apparatus and method |
| 06/16/2005 | US20050130182 Comparing: abundance of one or more marker polypeptides selected from the group consisting of: fibrinogen alpha -chain, fibrinogen beta -chain, fibrinopeptide A, in a patient sample, the normal abundance of the one or more of marker polypeptides in a sample from a control not afflicted with endometriosis |
| 06/16/2005 | US20050130180 Making a three-dimensional nucleic acid structure formed with a trimer by mixing at least three complementary polynucleotides in solution; each polynucleotide has a non-complementary sticky end; genetic engineering; high yield, purity |
| 06/16/2005 | US20050130179 Charge tags and the separation of nucleic acid molecules |
| 06/16/2005 | US20050130178 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures; polymerase chain reaction (PCR) |
| 06/16/2005 | US20050130177 Variable valve apparatus and methods |
| 06/16/2005 | US20050130176 Molecular beacon comprising an oligonucleotide stem-loop structure and having a photoluminescent dye for use in determining the presence of a selected genetic sequence in a population |
| 06/16/2005 | US20050130174 Using label-less gold-nanoparticle probes with silver enhancement to detect and identify global gene expression |
| 06/16/2005 | US20050130173 Methods of amplifying and sequencing nucleic acids |
| 06/16/2005 | US20050130172 Using methylation status of preferential tumor marker sequences as tool in diagnosis of colon and rectum cancer |